11/15/2018 | BK | Market Commentary: LMBE, Valeant, Chef’s Warehouse break; Openlink, MSX, GPS updated; Element accelerated
|
11/14/2018 | BK | Market Commentary: LifePoint, Infrastructure & Energy, Concrete Pumping break; Valeant, Openlink revise deals
|
11/14/2018 | BK | Valeant cuts spread on $1.5 billion term loan to Libor plus 275 bps
|
11/13/2018 | BK | Market Commentary: LifePoint, Valeant revise loans; Applied Systems firms terms; multiple deals come to market
|
11/13/2018 | BKCAHY | Valeant lifts term loan to $1.5 billion, cancels potential bond deal
|
11/8/2018 | BK | Market Commentary: AssetMark, PetVet break; WeddingWire, TRC tweak loans; multiple deals set talk with launch
|
11/8/2018 | BK | Valeant Pharmaceuticals talks $750 million term loan at 99-99.5 OID
|
11/8/2018 | BKCADDHY | Fitch rates Valeant loan BB-
|
11/7/2018 | BK | Market Commentary: PolyOne frees to trade atop OID; Information Resources, AssetMark, PetVet revise deals
|
11/7/2018 | BK | Valeant Pharmaceuticals to launch $750 million term loan on Thursday
|
5/17/2018 | BKCADDHY | Fitch rates Valeant facility BB-, notes B-
|
5/15/2018 | BKCAHY | Moody’s rates Valeant loans Ba3
|
5/8/2018 | BKCVDDEMIGPV | Market Commentary: Primary quiet; Gaming & Leisure active; Dish volatile; Sanchez Energy drops, Valeant gains
|
3/12/2018 | BKCAHY | S&P gives B- to Valeant notes
|
2/11/2016 | BK | Market Commentary: Bids on three BWICs come due; Alpha Media takes second crack at first-lien loan syndication
|
9/21/2012 | BKCVHY | Moody's: Valeant unaffected
|
7/6/2011 | BK | Valeant gets $200 million 18-month revolver at Libor plus 300 bps
|
5/3/2011 | BKCACVHY | Moody's confirms Valeant
|
3/9/2011 | BKCACVHY | S&P rates Valeant notes BB-
|
3/2/2011 | BKCACVHY | Moody's cuts Valeant to stable, rates notes Ba3
|
3/2/2011 | BKCACVHY | S&P rates Valeant notes BB-
|
3/1/2011 | BK | Valeant Pharmaceuticals to pay down term loan A, cancel revolver
|
2/7/2011 | BKCACVHY | S&P assigns Valeant loan BB+, notes BB-
|
2/3/2011 | BKCACVHY | Moody's rates Valeant notes B1
|
2/3/2011 | BKCACVHY | S&P rates Valeant notes BB-
|
9/23/2010 | BK | Market Commentary: DineEquity, Nalco, GenTek, others set price talk; Graham makes draw for acquisition close
|
9/22/2010 | BKCVHY | S&P revises Valeant notes to BB-
|
9/21/2006 | BKBTCVHY | Moody's revises ratings for nine U.S. pharma companies
|
5/23/2006 | BKBTHY | S&P lowers Valeant Pharmaceutical view to negative
|